Skip to content
Open access

DCE-MRI and Mammography integrated radiomic analysis in triple negative ductal invasive breast cancer patients. Comparison between BRCA and not BRCA mutated patients: preliminary results

Sep 2026 · European Journal of Radiology Open · Vol 17, pp. 100810 · 0 citations · 40 references
Medicine

TL;DR

A combined radiomic model based on features extracted from DCE-MRI and mammographic images to discriminate the mutational status of BRCA genes in patients with TNBC reinforces the feasibility of radiomics to predict BRCA mutation in patients with TNBC.

Abstract

Purpose We propose a combined radiomic model based on features extracted from DCE-MRI and mammographic images (MG) to discriminate the mutational status of BRCA genes in patients with TNBC. Material and methods This retrospective study included patients histologically diagnosed with TNBC who performed a mammography followed by a DCE-MRI between 2010 and 2021. A manual segmentation was performed on the entire tumor volume on both imaging modalities. Subsequently, a 5-mm ROI was placed within the segmented tumor volume and the contralateral healthy gland. Radiomic features were extracted from these ROIs using Pyradiomics and selected with Maximum Relevance Minimum Redundancy algorithm to fit different classifiers. A final model was developed by integrating the most predictive features extracted from lesion and healthy gland from both modalities into a single multivariate framework. Finally, the added value of an integrated approach was assessed by comparing the performance with single-modality radiomic models. Results The population included 52 patients for a total of 53 lesions (13 BRCA-mutated, 40 non BRCA-carriers). The highest classification performance for BRCA mutational status was achieved by Random Forest that integrated both MRI and mammography features, yielding an Area Under the Curve (AUC) of 0.91. Most predictive features were extracted from healthy gland regions and from MR wash-in/wash-out maps. Multimodal imaging analysis outperformed the best models of single-modality approaches (AUCMG-gland 0.827, AUCMR-gland+lesion 0.80). Conclusions This study reinforces the feasibility of radiomics to predict BRCA mutation in patients with TNBC, highlighting the possibility of integrating different imaging modalities to enhance model accuracy.

Read PDF

Similar papers

2026

Comparative study between contrast enhanced mammography and breast MRI in local pre-operative staging of invasive lobular carcinoma: A cross-sectional study.

MRI provides superior accuracy in assessing tumor size and disease extent and remains the preferred staging modality, however, CEM offers excellent performance in evaluating multifocality, multicentricity, and laterality, making it a valuable alternative when MRI is unavailable or contraindicated.

Micheal Saber Nan Georgy, R. H. Abdallah, Ahmed Gamal Eldeen Othman et al. · 0 citations
Aug 2026

MRI-based radiomics for non-invasive prediction of histopathological and immunohistochemical features in ductal carcinoma in situ: Implications for risk stratification

Background Differentiating the immunohistochemical and histopathological features of ductal carcinoma in situ (DCIS) lesions is critical to potentially enable future tailored treatment options and de-escalation strategies. Purpose To investigate the potential of magnetic resonance imaging (MRI) radiomics for the non-in...

A. A. Tan, Amir Bakhshandehpour, Ümran Esen et al. · 0 citations
Open access Sep 2026

Clinical–Radiomics Nomogram Based on 18F-FDG PET/CT for Distinguishing Lymphoma from Cancer of Unknown Primary in Head and Neck Metastatic Poorly Differentiated Cancer

The clinical–radiomics nomogram shows promising potential for differentiating lymphoma from CUP in poorly differentiated cervical lymph node malignancies and warrants further validation in larger, multi-center cohorts before clinical implementation.

Wen Chen, Ming-Zhen Xu, Bing-Xin Gu et al. · 0 citations
Open access Oct 2026

Accuracy of positron emission mammography for tumor size assessment and detection of other breast lesions in newly diagnosed breast cancer

Positron emission mammography (PEM) is a valuable tool for assessing the extent of disease in newly diagnosed breast cancer patients, particularly among women pursuing conservative surgical management. The aim of this study was to evaluate the added diagnostic value of preoperative Positron Emission Mammography (PEM) i...

E. Kamal, Mahmoud Mekhaimar, R. Hamid et al. · 0 citations
Sep 2026

Association of Contrast-Enhanced Mammography Imaging Features with Molecular Subtypes of Breast Cancer: A Cross-Sectional Study

Background: Breast cancer molecular subtypes differ biologically and may exhibit distinct imaging phenotypes. This study examined whether mammographic morphologic features corresponding to the low-energy structural component of contrast-enhanced mammography (CEM) were associated with molecular subtype. Methods: A retro...

Wael Ahmed Maher Mostafa ElHik · 0 citations
Aug 2026

Prediction of Residual Axillary Lymph Node Metastasis Following Neoadjuvant Therapy for Breast Cancer: Habitat Radiomics Analysis Based on Breast MRI.

RATIONALE AND OBJECTIVES To develop and validate a habitat radiomics model based on pretreatment breast magnetic resonance imaging (MRI) in predicting residual axillary lymph node metastasis (RALNM) after neoadjuvant therapy (NAT) in patients with clinically node-positive (cN+) breast cancer. MATERIALS AND METHODS Th...

Junjie Zhang, Yi Dai, Ruxin Xu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.